Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Standing Firm with Core Values, MNCs Shall Be Able to Hold Their Grounds in Chin... Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on recent healthcare reform moves, in particular those relat... (9/3/2018) Impending Tariffs on China to Impact Manufacturers of Dietary Supplements, OTC Drugs and Cosmetics (9/21/2018) Should You Look At China For Your Next Clinical Trial? (9/20/2018) AstraZeneca Plots China Robot Offensive to Counter Price Cuts (9/19/2018) R&D Cooperation Between China and Western Pharma Companies Up 70% (9/18/2018) Fosun Pharma Sees 'Huge' Opportunities in India, Southeast Asia, Africa (9/18/2018) Can A Cancer Drug Originated In China Be A Success In The U.S.? (9/14/2018) China's Largest Drug Retailer Plans Next Milestones to Scale Business Following U.S. IPO (9/14/2018) The TKI Lung Cancer Market in China (9/10/2018) Standing Firm with Core Values, MNCs Shall Be Able to Hold Their Grounds in China despite Economic Slowdown (9/3/2018) An American Pharmaceutical Entrepreneur Achieves Billionaire Status -- In China (8/30/2018) Why Chinese Biotech Inventions Have Yet to Make an Impact Globally, Despite Patenting Surge (8/29/2018) Bloomburg: Wall Street Expats Angle for Piece of China’s Biotech Drug Boom (8/29/2018) FT: China Health Reforms Help Global Pharma Groups Despite Price Cuts? (8/27/2018) The Impact of Scientific Data Administrative Measures on Foreign Companies in China (8/21/2018) Shanghai Regulator: Speaking Fees to Physicians Constitute Bribery (8/14/2018) Recent Executive Moves  (9/21/2018) CPA Releases Announcement for Excessivel...  (9/21/2018) Fitch: Increased Use of Technology Will ...  (9/21/2018) Nicholas Hall Reports Growth of Chinese ...  (9/20/2018) CDE Solicits Comments on Core Considerat...  (9/20/2018) CDE Seeks Comments on Draft Chinese Tran...  (9/20/2018) China Medical System Signs License and P...  (9/20/2018) Allergan to Build First Medical Aestheti...  (9/20/2018) Innovent Reports Clinical Data of Sintil...  (9/20/2018) BeiGene Selects GE's KUBio for Its mAb F...  (9/20/2018) (free) Wuxi AppTech Submitted $1B+ IPO Applicat...  (9/20/2018) Roche Announces Plan to Build An Innovat...  (9/20/2018) State Council Introduces New Policy to I...  (9/19/2018) Merck Slashes Price of Anticancer Keytru...  (9/19/2018) Lilly China and Microsoft Enter Digital ...  (9/19/2018) Top 25 Global Pharmaceutical Companies by Market Cap 201... CANbridge Receives IND Approval to Commence CAN008 Phase... Global Contract Pharmaceutical Manufacturing Market to R... White House Task Force Echoes Pharma Proposals Pharma Industry Reputation Rebounds Somewhat in 2016 Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Mar... Snapshot of Chinese Public Hospital Vaccine Consumption 2017 China CDMO Market 2018-2021: The R&D Cost of New Drugs Cont... IQVIA: Chinese Hospital Drug Market Up 3.7% in MAT Q1/2018 IQVIA: Chinese Retail Pharmacy Market Surged 4.6% in MAT Q1/201... China Medical System Signs License and Partnership Deal with... Allergan to Build First Medical Aesthetics Innovation Center... BeiGene Selects GE's KUBio for Its mAb Facility in Guangzhou... Wuxi AppTech Submitted $1B+ IPO Application in Hong Kong Roche Announces Plan to Build An Innovation Center in Shangh... CPA Releases Announcement for Excessively-Supplied Drug ... CDE Solicits Comments on Core Considerations for Clinica... CDE Seeks Comments on Draft Chinese Translations of Seve... NMPA Releases List of Reference Formulations for Generic... NMPA's Official Responsibilities and Internal Organizati... Chinese American Scientist Admits Plot to Steal GSK's Secret... Trump Lashes Out on China and Mexico for Opioid and Fentanyl... Gilead's Key Sovaldi Patent Claims Partially Invalidated in ... China To Establish More Intellectual Property Protection Cen... Shanghai AIC Officially Terminates Antimonopoly Investigatio... EU, U.S. and Canada Investigating Second Impurity in Hua... EU Regulators Issue Notice on a Chinese Anticancer API A... USFDA Recalls Thyroid Drugs Containing Chinese API over ... Indian Drugmakers Hit by Rising Prices of Chinese Interm... FDA Warns Four Manufacturers from China, India and Canad... Innovent Reports Clinical Data of Sintilimab as First-li... CBT Pharma Initiates the APOLLO Oncology Clinical Trials... EpimAb Announces IND Filing for EMB01 in China and the U... Chinese Drug-releasing Heart Stent Clears Clinical Trial... Innovent Receives Chinese IND Approval for mAb Drug Cand... Fitch: Increased Use of Technology Will Improve Healthca... State Council Introduces New Policy to Improve the Natio... NHC Issues Regulation to Improve Health and Medical Big ... NHC Issues the Provisions for Clinical Application of Me... NHC Issues Three New Rules to Guide and Regulate Develop... Recent Executive Moves Recent Official and Executive Movements Recent Executive Moves Eric Bouteiller Joins Advisory Board of WiCON|Pharma China... Recent Executive Moves Upcoming Event: Shanghai eHealth Workshop Upcoming Event: World Congress on Virology 2018 Upcoming Event: GUT Health Congress Asia 2018 Upcoming Event: 5th World Congress on Epigenetics and Ch... Upcoming Event: 7th International Conference on Neurolog... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Its...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links